RNA5SP318

Across TCGA pan-cancer cohorts, RNA5SP318 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNA5SP318 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNA5SP318 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP318 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

SKCM, STAD, and KIRC are the cancer types where RNA5SP318 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.036	0.738	<.001	108	view →
STAD	OS	Tertile	II,III,IV	0.061	0.711	<.001	36	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
THCA	OS	Tertile	III,IV	0.240	0.795	.006	27	view →
ESCA	DFS	Tertile	III,IV	1.000	0.273	.020	24	view →
LUAD	OS	Tertile	II,III,IV	0.266	0.749	.027	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNA5SP318–SKCM (DFS)

Open the SKCM breakdown →